Results 191 to 200 of about 14,094 (223)

Efficacy, Safety and PK of Once-Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model-Informed Drug Development Approach. [PDF]

Diabetes Obes Metab
Overgaard RV, Birkhan O, Rathor N, Sparsø T, Strathe A, Wharton S, Rubino D.   +6 more
europepmc   +1 more source

Semaglutide in obesity and type 2 diabetes: A review of clinical trial evidence from 1 to 5 semaglutide treatment effect in people with obesity program.

Indian J Pharmacol
Khanna A, Kumar V, Gola S.
europepmc   +1 more source

Semaglutide and Resmetirom in Patients With Metabolic Dysfunction‐Associated Steatohepatitis and Fibrosis: An Exploratory Indirect Comparison

Diabetes, Obesity and Metabolism, EarlyView.
Alessandro Mantovani, Giovanni Targher
wiley   +1 more source

Erratum. [PDF]

Obes Facts
europepmc   +1 more source

Semaglutide

Reactions Weekly
  +36 more sources